Following up on a 2018 study that identified an epigenetic modifier known as histone deacetylase 11 (HDAC11) as a potential therapeutic target for treating obesity and diabetes, researchers have published new research that finds HDAC11 regulates G protein-coupled receptors.
Click here for original story, New method for stimulating signaling to improve metabolic health and possibly treat obesity
Source: ScienceDaily